Concepedia

Author

Keiji Imai

Astellas Pharma (Japan)

Also Known As

Keiji IMAI, Keiji Imai

23

Publications

483

Citations

8

H-Index

17

Concepts

All Affiliations

Astellas Pharma (Japan)Toho UniversityPfizer (United States)Okayama UniversityPfizer (Japan)
KI

About

Keiji Imai is an author at Astellas Pharma (Japan) specializing in pharmacology, medicine, and biomedical engineering.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

166

2

Biomedical Engineering

2

2

169

3

Engineering

1

1

15

4

Natural Sciences

1

1

43

5

Chemistry

1

1

43

Keiji Imai

×

8

Publications

458

Citations

8

H-Index

YearCitations

Key predictive factors of axitinib (AG-013736)-induced proteinuria and efficacy: A phase II study in Japanese patients with cytokine-refractory metastatic renal cell Carcinoma

Yoshihiko Tomita, Hirotsugu Uemura, Hiroyuki Fujimoto,

European Journal of Cancer

2011

123

Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): In vivo evaluation

Nobuyuki Tanaka, Keiji Imai, Kazuto Okimoto,

Journal of Controlled Release

2006

93

Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine

Nobuyuki Tanaka, Keiji Imai, Kazuto Okimoto,

Journal of Controlled Release

2005

76

Phase I and pharmacokinetic study of dacomitinib (PF-00299804), an oral irreversible, small molecule inhibitor of human epidermal growth factor receptor-1, -2, and -4 tyrosine kinases, in Japanese patients with advanced solid tumors

Toshiaki Takahashi, Narikazu Boku, Haruyasu Murakami,

Investigational New Drugs

2012

63

Process analytical technology applied for end-point detection of pharmaceutical blending by combining two calibration-free methods: Simultaneously monitoring specific near-infrared peak intensity and moving block standard deviation

Wataru Momose, Keiji Imai, Shoji Yokota,

Powder Technology

2011

43

Applying terahertz technology for nondestructive detection of crack initiation in a film-coated layer on a swelling tablet

Wataru Momose, Hiroyuki Yoshino, Yoshifumi Katakawa,

Results in Pharma Sciences

2012

29

Efficacy and Safety of Bococizumab (RN316/PF-04950615), a Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, in Hypercholesterolemic Japanese Subjects Receiving a Stable Dose of Atorvastatin or Treatment-Naive　― Results From a Randomized, Placebo-Controlled, Dose-Ranging Study ―

Koutaro Yokote, Shigeto Kanada, Osamu Matsuoka,

Circulation Journal

2017

16

Optimization of the Manufacturing Process for Oral Formulations Using Multivariate Statistical Methods

Tadashi Norioka, Shingo Kikuchi, Yoshinori Onuki,

Journal of Pharmaceutical Innovation

2011

15

Page 1